Ariosa's non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million ...
Labcorp’s testing capabilities are getting a little broader with the $237.5 million acquisition of certain laboratory assets from BioReference Health, a subsidiary of Opko Health. The BioReference ...
Bio-Reference Laboratories (NASDAQ: BRLI) reported earnings on June 6. Here are the numbers you need to know. The 10-second takeaway For the quarter ended April 30 (Q2), Bio-Reference Laboratories met ...